PGI 0010
Alternative Names: PGI-0010Latest Information Update: 20 Apr 2007
At a glance
- Originator PsychoGenics
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Attention-deficit hyperactivity disorder
Most Recent Events
- 11 Oct 2002 Preclinical trials in Attention-deficit hyperactivity disorder in USA (unspecified route)